# Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product

> **NCT05332106** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 10 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet
- **DRUG:** Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet

## Key facts

- **NCT ID:** NCT05332106
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-12
- **Primary completion:** 2022-03-22
- **Final completion:** 2022-03-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332106, "Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05332106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*